Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BIORA THERAPEUTICS, INC.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
BIORA THERAPEUTICS, INC.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
BIORA THERAPEUTICS, INC.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
BIORA THERAPEUTICS, INC.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
BIORA THERAPEUTICS, INC.Listing on record | Buy | $50M | conv 57ClusterFirst in 12mo | SEC | |
VERENIUM CORPListing unverified | Other | $11.7M | SEC | ||
VERENIUM CORPListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
VERENIUM CORPListing unverified | Other | $7.3M | SEC |